BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22972813)

  • 1. Mammographic screening programmes in Europe: organization, coverage and participation.
    Giordano L; von Karsa L; Tomatis M; Majek O; de Wolf C; Lancucki L; Hofvind S; Nyström L; Segnan N; Ponti A; ; Van Hal G; Martens P; Májek O; Danes J; von Euler-Chelpin M; Aasmaa A; Anttila A; Becker N; Péntek Z; Budai A; Mádai S; Fitzpatrick P; Mooney T; Zappa M; Ventura L; Scharpantgen A; Hofvind S; Seroczynski P; Morais A; Rodrigues V; Bento MJ; Gomes de Carvalho J; Natal C; Prieto M; Sánchez-Contador Escudero C; Zubizarreta Alberti R; Fernández Llanes SB; Ascunce N; Ederra Sanza M; Sarriugarte Irigoien G; Salas Trejo D; Ibáñez Cabanell J; Wiege M; Ohlsson G; Törnberg S; Korzeniewska M; de Wolf C; Fracheboud J; Patnick J J; Lancucki L; Ducarroz S; Suonio E
    J Med Screen; 2012; 19 Suppl 1():72-82. PubMed ID: 22972813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report of introducing population-based breast cancer screening in Poland: experience of the 3-million population region of Lower Silesia.
    Matkowski R; Szynglarewicz B
    Cancer Epidemiol; 2011 Dec; 35(6):e111-5. PubMed ID: 21840281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.
    Hofvind S; Ponti A; Patnick J; Ascunce N; Njor S; Broeders M; Giordano L; Frigerio A; Törnberg S; ; Van Hal G; Martens P; Májek O; Danes J; von Euler-Chelpin M; Aasmaa A; Anttila A; Becker N; Péntek Z; Budai A; Mádai S; Fitzpatrick P; Mooney T; Zappa M; Ventura L; Scharpantgen A; Hofvind S; Seroczynski P; Morais A; Rodrigues V; Bento MJ; Gomes de Carvalho J; Natal C; Prieto M; Sánchez-Contador Escudero C; Zubizarreta Alberti R; Fernández Llanes SB; Ascunce N; Ederra Sanza M; Sarriugarte Irigoien G; Salas Trejo D; Ibáñez Cabanell J; Wiege M; Ohlsson G; Törnberg S; Korzeniewska M; de Wolf C; Fracheboud J; Patnick J; Lancucki L; Ducarroz S; Suonio E
    J Med Screen; 2012; 19 Suppl 1():57-66. PubMed ID: 22972811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies.
    Njor S; Nyström L; Moss S; Paci E; Broeders M; Segnan N; Lynge E;
    J Med Screen; 2012; 19 Suppl 1():33-41. PubMed ID: 22972809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coverage in the National Health Service Breast Screening Programme, 1996-2005: correcting for the first invitation of women between 50 and 52 years.
    Bennett RL; Blanks RG; Moss SM
    J Public Health (Oxf); 2008 Jun; 30(2):167-70. PubMed ID: 18339650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European transnational ecological deprivation index and participation in population-based breast cancer screening programmes in France.
    Ouédraogo S; Dabakuyo-Yonli TS; Roussot A; Pornet C; Sarlin N; Lunaud P; Desmidt P; Quantin C; Chauvin F; Dancourt V; Arveux P
    Prev Med; 2014 Jun; 63():103-8. PubMed ID: 24345603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European centres.
    Törnberg S; Codd M; Rodrigues V; Segnan N; Ponti A
    J Med Screen; 2005; 12(1):43-9. PubMed ID: 15814019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of socio-economic variables in cancer screening participation: a comparison between population-based and opportunistic screening in the EU-15.
    Walsh B; Silles M; O'Neill C
    Health Policy; 2011 Aug; 101(3):269-76. PubMed ID: 21420755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of invitation schemes on breast cancer screening coverage: A cohort study from Copenhagen, Denmark.
    Jacobsen KK; von Euler Chelpin M; Vejborg I; Lynge E
    J Med Screen; 2017 Mar; 24(1):20-26. PubMed ID: 27206815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast and cervical cancer screening in Spain and predictors of adherence.
    Martín-López R; Hernández-Barrera V; De Andres AL; Garrido PC; De Miguel AG; García RJ
    Eur J Cancer Prev; 2010 May; 19(3):239-45. PubMed ID: 20110817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening policies and coverage in Europe.
    Anttila A; von Karsa L; Aasmaa A; Fender M; Patnick J; Rebolj M; Nicula F; Vass L; Valerianova Z; Voti L; Sauvaget C; Ronco G
    Eur J Cancer; 2009 Oct; 45(15):2649-58. PubMed ID: 19699081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies.
    Moss SM; Nyström L; Jonsson H; Paci E; Lynge E; Njor S; Broeders M;
    J Med Screen; 2012; 19 Suppl 1():26-32. PubMed ID: 22972808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence, characteristics and equity of access to breast cancer screening programmes in 27 European countries in 2010 and 2014. Results from an international survey.
    Deandrea S; Molina-Barceló A; Uluturk A; Moreno J; Neamtiu L; Peiró-Pérez R; Saz-Parkinson Z; Lopez-Alcalde J; Lerda D; Salas D
    Prev Med; 2016 Oct; 91():250-263. PubMed ID: 27527575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic screening for breast cancer: 2010.
    Margolies L
    Mt Sinai J Med; 2010; 77(4):398-404. PubMed ID: 20687187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer screening programmes: challenging the coexistence with opportunistic mammography.
    Ouédraogo S; Dabakuyo-Yonli TS; Amiel P; Dancourt V; Dumas A; Arveux P
    Patient Educ Couns; 2014 Dec; 97(3):410-7. PubMed ID: 25282326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effectiveness of population-based breast cancer screening programme].
    Szynglarewicz B; Matkowski R; Kasprzak P; Kotowska J; Forgacz J; Pudełko M; Kornafel J
    Pol Merkur Lekarski; 2009 Feb; 26(152):117-20. PubMed ID: 19388515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invitation strategies and coverage in the population-based cancer screening programmes in the European Union.
    Vale DB; Anttila A; Ponti A; Senore C; Sankaranaryanan R; Ronco G; Segnan N; Tomatis M; Žakelj MP; Elfström KM; Lönnberg S; Dillner J; Basu P
    Eur J Cancer Prev; 2019 Mar; 28(2):131-140. PubMed ID: 29570103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammography screening in Denmark.
    Vejborg I; Mikkelsen E; Garne JP; Bak M; Lernevall A; Mogensen NB; Schwartz W; Lynge E
    Dan Med Bull; 2011 Jun; 58(6):C4287. PubMed ID: 21651881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.